Posted by med_empowered on March 18, 2006, at 17:08:01
In reply to Re: to EDUK, med update » Jeroen, posted by psychopharmacon on March 18, 2006, at 14:02:45
hi! how are you doing? The previous poster made a good point--some of the newer APs seem helpful for established cases of TD. There seems to be a good number of positive reports for Abilify, but that might just be b/c its the newest drug available (in the US, at least). Also, Abilify works a little differently--it "occupies" a higher percentage of D2 receptors (up to 90% plus) than the other atypicals; however, it doesn't seem to cause very much EPS, and the TD risk **seems** to be low. So..the theory (as I understand it) is that TD results in part from dopamine sensitivity; since abilify reduces and increases dopamine levels, the idea is that maybe it could make an effective TD treatment.
Good luck!
poster:med_empowered
thread:621652
URL: http://www.dr-bob.org/babble/20060315/msgs/621707.html